SNCA and Lewy body dementia: A recent meta-analysis showed 0.91 diagnostic sensitivity and 0.96 specificity of seeding amplification assays investigating CSF alpha-synuclein in Lewy body disease [27], thus supporting seeding amplification assays for alpha synuclein as promising biomarkers in DLB, and probably DLB’s prodromal stages.